Research And Development Expense, Clinical Trials
Inhibrx Biosciences, Inc.·Business Segments·1 segment
Breakdown
Segments
Business SegmentsView metric
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 |
|---|---|---|---|---|
| Business Segments | $13.27M | $4.08M | $11.85M | $9.18M |
| Total | $13.27M | $4.08M | $11.85M | $9.18M |